INVESTORS’ RIGHTS AGREEMENTInvestors’ Rights Agreement • August 10th, 2018 • Allogene Therapeutics, Inc. • Biological products, (no disgnostic substances) • Delaware
THIS INVESTORS’ RIGHTS AGREEMENT (this “Agreement”), is made as of April 6, 2018 by and among Allogene Therapeutics, Inc. a Delaware corporation (the “Company”), each of the investors listed on Schedule A hereto, each of which is referred to in this Agreement as an “Investor.”
BRITANNIA POINTE GRAND BUSINESS PARK LEASELease • August 10th, 2018 • Allogene Therapeutics, Inc. • Biological products, (no disgnostic substances) • California
This Lease (the “Lease”), dated as of the Execution Date set forth in Section 1 of the Summary of Basic Lease Information (the “Summary”), below, is made by and between BRITANNIA POINTE GRAND LIMITED PARTNERSHIP, a Delaware limited partnership (“Landlord”), and ALLOGENE THERAPEUTICS, INC., a Delaware corporation (“Tenant”). Landlord and Tenant may each be referred to in this Lease individually as a “Party” and collectively as the “Parties.”
